Do adverse events during anti-PD-1 therapy correlate with tumor mutational burden?
- Posted on: Oct 17 2019
- Leave a response
This retrospective study assessed the relationship between serious immune-related adverse events during anti-PD-1 cancer therapy and tumor mutational burden.
Source: AAO
Posted in: Uncategorized